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Introduction
Klinefelter syndrome (KS) is the most common sex-chromosome aneuploidy in humans, affecting approximately 1 in every 600 newborn males. 1 Most individuals with KS carry one extra X-chromosome (karyotype 47,XXY), although other reported variants include 48,XXXY, 48,XXYY and 49,XXXXY. 2 The condition presents with a broad range of phenotypes that often vary in severity. 2 In addition to the well-characterized physical and physiological features-tall stature, gynecomastia, hypogonadism, and absent spermatogenesis 3 -KS is also often associated with psychiatric and neurodevelopmental phenotypes including language-based learning disabilities, decreased verbal intelligence and difficulties with task planning and inhibitory control. 4 Of note, individuals with KS frequently exhibit symptoms related to schizophrenia including schizotypal traits, 5 auditory hallucinations 6 and verbal cognition impairment. 7 Furthermore, several structural brain abnormalities are associated with the disorder including abnormal cerebral asymmetry 8, 9 and reductions in the size of specific brain regions, 6 ,10,11 total brain volume, 10, 12, 13 and white matter volume. 9, 10 The mechanism(s) by which the supernumerary X-chromosome determines the phenotypes evident in KS are poorly understood, although skewed X-chromosome inactivation (XCI), gene-dosage dysregulation, and the parental origin of the extra X-chromosome have all been implicated, [14] [15] [16] suggesting that epigenetic processes play an important role. However, little is known about the specific epigenetic changes associated with KS, especially in tissues relevant to the KS phenotype. A study comparing global long interspersed nucleotide element-1 (LINE-1) DNA methylation in whole blood from individuals with Turner's syndrome (45, XO) , healthy males (46,XY), healthy females (46, XX) and KS patients (47, XXY) reported that increased chromosomal number was associated with hypomethylation across the genome. 17 Studies of genome-wide patterns of DNA methylation in patients with trisomy 21 18 and trisomy 8 19 also reveal large changes not limited to the supernumerary chromosome, indicating that widespread epigenetic changes may be a common feature of chromosomal aneuploidy. Moreover, differences in brain morphology have been associated with imprinting of the X-chromosome in Turner Syndrome, indicating that the parental origin of the X-chromosome may be important in mediating the psychiatric symptoms present in sex abnormalities. 20 This study is the first to examine genome-wide patterns of DNA methylation and gene expression in two regions of the brain obtained post-mortem from a patient with a 47,XXY karyotype. We identify widespread tissue-specific epigenomic and transcriptomic alterations, providing potential clues about the molecular causes and consequences of KS.
Results and Discussion
As part of an integrated "-omics" study of schizophrenia (Pidsley et al., submitted), we examined genome-wide patterns of DNA methylation, gene expression, and genetic variation in postmortem cerebellum and prefrontal cortex brain tissue samples from schizophrenia patients and controls. During the standard quality control steps of these data we identified a discrepancy between reported and measured sex for one schizophrenia patient who displayed the genomic characteristics expected of both male and female samples simultaneously. As expected, across the entire set of samples, males and females showed distinct levels of DNA methylation across probes on the X-chromosome, with the exception of one sample recorded as male, who clustered with the female samples (Fig. S1A) . This individual also clustered with females for XIST gene expression (Fig. S2A) but with males when DNA methylation and gene expression across the Y-chromosome were assessed (Figs. S1B and S2B). A 47,XXY karyotype was confirmed via the high-resolution SNP genotyping array data (Figs. S3 and S4 ) and the presence of the Y-chromosome was confirmed via a PCR-based sex-typing assay (Fig. S5) . A number of other genomic alterations were identified in this individual (Table S1) , although there was no obvious excess burden of autosomal copy number variations (CNVs), except for one region with four copies of a region spanning the NKAIN2 locus. This is notable since copy number changes in this gene have previously been reported in neuropsychiatric phenotypes including neurodevelopmental disorders and schizophrenia. [21] [22] [23] [24] The patient's autopsy report did not record KS, suggesting that the 47,XXY karyotype was undetected during the patient's lifetime, although we did not have access to detailed pre-mortem medical records. In addition to schizophrenia, the autopsy report highlighted that the 47,XXY patient had a poor nutritional state, hepatomegaly, vascular spiders, nystagmus, dysdyadocokinesia, some degree of ataxia at the time of death, a known history of alcohol abuse and were prescribed the medications parentrocite and sulpiride.
Identifying structural brain abnormalities associated with a 47,XXY karyotype is of relevance given the established link between KS and several neuropsychiatric disorders including schizophrenia. 5, 25 Detailed records taken by the neuropathologist at autopsy show that although the 47,XXY patient had a similar total brain mass to other patients (47,XXY = 1417 g, all other samples = 1410 ± 182 g, other males = 1454 ± 201 g, females = 1325 ± 92 g) they had a markedly lower cerebellum mass (47,XXY = 111 g, all other samples = 170 ± 24 g, other males = 175 ± 27 g, females = 160 ± 15 g), equating to more than two standard deviations below the mean of the other samples ( Fig. 1; Fig. S6 ). The reduced cerebellum mass is consistent with the patient's autopsy report of movement disorders, and previous studies demonstrate an association between cerebellar ataxia and reduced cerebellar size. 26 Reductions in cerebral volume and decreased cortical thickness in the left inferior frontal, temporal, and superior motor regions have been previously reported in KS, 13 and a recent imaging study showed significant reductions in the volume of several brain regions, including the cerebellum, in KS patients compared with controls. 10 Other studies have also described brain abnormalities in KS patients, including reductions in total brain volume, 12 specific brain regions 6, 11 and white matter volume, 9 as well as abnormal cerebral asymmetry. 8, 9 These latter findings are consistent with the theory that brain asymmetry and cerebral dominance in humans is determined by a XY homologous gene pair. 27 Structural brain abnormalities have also been identified in patients with other types of X-chromosome aneuploidy 28 ; a recent study reported increased cerebellum volume in Turner syndrome (45,XO) patients, contrasting with the decreased cerebellum volume in our patient (47,XXY). 20 However, because reduced cerebellum mass has been associated with alcoholism 29 it is possible that the reduction observed in the 47,XXY patient is related to the their alcohol abuse history.
Global DNA methylation levels were estimated in both brain regions across all individuals using bisulfite-pyrosequencing assays targeting LINE-1 and Alu repeat elements across the genome, as described previously. 30, 31 Relative to other samples, the 47,XXY patient was a striking hypomethylated outlier across both LINE-1 (47,XXY = 67.7%, other samples = 73.0 ± 2.3%) and Alu (47,XXY = 25.5%, other samples = 28.1 ± 2.6%) repetitive elements in the prefrontal cortex ( Fig. 2A and B; Fig. S7A and B). Conversely in the cerebellum, the 47,XXY individual showed notable hypermethylation compared with the other samples at LINE-1 repetitive elements (47,XXY = 78.4%, other samples = 71.9 ± 2.1%), although no significant difference was observed at Alu repetitive elements (47,XXY = 24.7%, other samples = 24.8 ± 0.8%) ( Fig. 2C and D; Fig. S7C and D) .
Using the Infinium HumanMethylation450 BeadChip (Illumina Inc.) we identified numerous autosomal regions showing consistent differential DNA methylation in the 47,XXY patient compared with other samples (Tables 1 and 2 ). Of note, a region within the sperm-associated antigen 1 (SPAG1) gene is significantly hypermethylated in both the prefrontal cortex and the cerebellum, an interesting observation in the context of the infertility associated with KS given the role of this gene in spermatogenesis, fertilization, and infertility. 32 Other differentially methylated regions (DMRs) were found to be tissue-specific, and/or only detectable relative to either female or male controls. Of potential relevance to KS, for example, are cerebellar DMRs in the vicinity of Piwi-like protein 1 (PIWIL1), which plays a role in the self-renewal of germline stem cells. 33 Also of interest, given the cerebellar abnormalities seen in this individual, is evidence for cerebellum-specific hypermethylation of the LIM/homeobox 4 (LHX4) gene; mutations in this gene have been associated with altered brain development and cerebellar structure. 34 Given the comorbid diagnosis of schizophrenia in this patient, it is interesting that several of the prefrontal cortex DMRs are located in close proximity to other neurobiologically-relevant genes, including NOTCH4, EPHB3 and KCNN1, that have been previously implicated in schizophrenia, 35 brain development, [36] [37] [38] and regulation of microglia and neurons during neuroinflammation. 38 The large differences in DNA methylation reported here are specific to the XXY individual; none of these regions are significantly differentially methylated in our analysis of schizophrenia and matched controls (Pidlsey et al., submitted).
Numerous genes were found to be differentially expressed (DE) in the 47,XXY prefrontal cortex and cerebellum compared with other samples (Tables 3 and 4 ) with a Bonferronicorrected z-score P value < 0.05. In both brain regions the vast majority of DE genes were characterized by increased expression in the 47,XXY patient (prefrontal cortex: 12 loci significantly upregulated, 1 locus significantly downregulated; cerebellum: 18 loci significantly upregulated, 0 loci significantly downregulated), suggesting that the supernumerary X-chromosome may be upregulating transcription at multiple autosomal loci across the genome. Although some DE genes were observed only in Light gray boxes indicate non-significant results. Dark gray boxes indicate that no comparison was made (X-chromosome-linked genes were compared with females only whereas Y-chromosome-linked genes were compared with males only).
comparisons with both 46,XY males and 46,XX females, most were sex-comparison-specific. Strikingly, across both brain regions, many more 47,XXY DE genes were observed in comparison with females than males in both tissues (prefrontal cortex: 47,XXY vs females = 59, 47,XXY vs males = 18; cerebellum: 47,XXY vs females = 50, 47,XXY vs males = 21). Furthermore, although some changes were consistently observed in both the prefrontal cortex and cerebellum (e.g., CAMP, EPCAM and LOC441208), the majority were tissue-specific to a single brain region. The large differences in gene expression reported here are specific to the 47,XXY individual; none of these transcripts are differentially expressed in our analysis of schizophrenia and matched controls (Pidlsey et al., submitted). Given previous evidence that KS is associated with skewed XCI in peripheral blood, 14 we next assessed allelic patterns of DNA methylation in the proximity of a polymorphic repeat (CAG) n in the androgen receptor (AR) gene. Although the prefrontal cortex was characterized by subtle allelic imbalance of XCI (7.5% skewing), this did not exceed the range of normal skewing observed in our previous analysis of healthy individuals, 40 and there was no evidence of allelic skewing in the cerebellum (0.4% skewing). We were also interested in examining the expression and DNA methylation status of X-linked genes believed to escape XCI in females. 41 Between 5 and 15% of genes on the X-chromosome are thought to escape XCI in healthy females, 42, 43 and it has been suggested that these loci may play an important role in the KS phenotype. 44, 45 Although genes escaping XCI might be expected to show consistently high expression levels in females compared with males, many loci actually show variable levels of expression in females 46 with evidence of tissue-specificity. 45, 47 Although the 47,XXY patient is an outlier for the expression of many genes thought to escape XCI, we find no consistent pattern of altered transcription; some loci are upregulated and others downregulated, with many showing changes specific to either male or female comparison groups (Table S2 ). There is also considerable evidence for tissue-specific differences in the expression of these genes, concurring with data from a study of genes escaping XCI in 41,XXY mice compared with karyotypically normal male and female mice. 45 One of the loci showing noticeably higher expression in the 47,XXY patient compared with both females and males across both brain regions is the gene encoding Eukaryotic Translation Initiation Factor 1AX (EIF1AX ) (Fig. S8) , which has been suggested as a possible candidate gene for Turner syndrome (45,XO). 48 Browseable tracks for viewing within the Integrative Genomics Viewer (IGV) (http:// www.broadinstitute.org/igv/home) showing 47,XXY-associated changes in DNA methylation and gene expression for other loci are downloadable from our laboratory website (http://epigenetics.iop.kcl.ac.uk/XXY).
We also looked at the expression of genes located in the pseudoautosomal regions (PAR) 1 and 2 49 (http://www.genenames. org/genefamilies/PAR), which are represented by three copies in individuals with a 47,XXY karyotype. Again, although often an outlier for transcription at these loci (Table S3) , the observed pattern in the 47,XXY individual is heterogeneous, differing across tissues and between male and female comparison groups. Some PAR genes (e.g., SLC25A6 ) are clearly upregulated in the cerebellum but not the prefrontal cortex, while others (e.g., DHRSX ) are upregulated across both tissues. Other genes such as GTPBP6, for example, are consistent outliers for reduced expression in the 47,XXY patient suggesting that transcription is not always positively correlated with copy number in the PAR. Further work is needed to explore the regulatory mechanisms influencing expression of loci on the extra X-chromosome, and the processes involved in controlling dosage compensation. Another region of interest in KS is the X transposed region (XTR) on the Y chromosome, 50 created by a 3.5 Mb duplication from Xq21.3 to Yp11.2 during hominin evolution. [51] [52] [53] In Figure S4 the allele frequency plot for the 46,XY male (B) shows three bands across both chromosomal regions, whereas the 47,XXY patient (A) is characterized by four bands, most likely resulting from cross hybridization of microarray probes. Although epigenetic deregulation of the Protocadherin 11 X-linked (PCDH11X) and Y-linked (PCDH11Y) genes in these regions are of great interest in KS and neuropsychiatric disease, [54] [55] [56] DNA methylation array probes in the vicinity of these genes were excluded during our stringent quality control steps due to cross-reactivity 57 and could not be assessed in this study (see the "Materials and Methods" section). Because it is plausible that the XTR contains sequence and epigenetic differences that are important in KS and schizophrenia, future studies should utilize methods that can unambiguously profile variation in this region.
In summary, this study identifies widespread transcriptomic and epigenomic changes in the prefrontal cortex and cerebellum associated with a 47,XXY karyotype. Although our findings are based on data from only a single 47,XXY individual, and it will be important to confirm the observed patterns samples from additional patients, this study represents the first detailed molecular characterization of brain tissue from an individual with a 47,XXY karyotype. The patient, who was comorbid for schizophrenia, was found to have a notably reduced cerebellum mass and was characterized by considerable locus-specific changes in Light gray boxes indicate non-significant results. Dark gray boxes indicate that no comparison was made (X-chromosome-linked genes were compared with females only whereas Y-chromosome-linked genes were compared with males only).
DNA methylation and gene expression, with many of these differences being autosomal and tissue-specific. Strikingly, global DNA methylation, assessed via the interrogation of LINE-1 and Alu repetitive elements, was significantly altered in the 47,XXY patient in a tissue-specific manner. Finally, we find evidence for alterations in gene expression at loci believed to normally escape XCI in females. Light gray boxes indicate non-significant results. Dark gray boxes indicate that no comparison was made (X-chromosome-linked genes were compared with females only whereas Y-chromosome-linked genes were compared with males only). *cNV with copy number of 3 overlapping with the region (see Table S1 ). Light gray boxes indicate non-significant results. Dark gray boxes indicate that no comparison was made (X-chromosome-linked genes were compared with females only whereas Y-chromosome-linked genes were compared with males only). annotation data for each probe obtained using the Bioconductor package illuminahumanv4.db. Light gray boxes indicate non-significant results. Dark gray boxes indicate that no comparison was made (X-chromosome-linked genes were compared with females only whereas Y-chromosome-linked genes were compared with males only). annotation data for each probe obtained using the Bioconductor package illuminahumanv4.db. Light gray boxes indicate non-significant results. Dark gray boxes indicate that no comparison was made (X-chromosome-linked genes were compares to females only whereas Y-chromosome-linked genes were compared with males only). annotation data for each probe obtained using the Bioconductor package illuminahumanv4.db.
Materials and Methods

Samples and nucleic acid isolation
39
patients were diagnosed pre-mortem by psychiatrists in the UK using standardized diagnostic criteria. Demographic information about the samples is summarized in Table S4 . Genomic DNA was extracted from each tissue sample using a standard phenolchloroform extraction and tested for purity and degradation using spectrophotometry and gel electrophoresis, respectively. RNA was extracted using a standard Trizol extraction method and purified using an RNeasy Mini Kit with DNase I digestion (Qiagen), according to manufacturer's instructions. RNA was tested for degradation and purity using an Agilent 2100 Bioanalyzer and RNA 6000 Nano kit (Agilent Technologies). All samples were randomized with respect to gender and disease status throughout all stages of the project to avoid potential batch effects. Global DNA methylation assay Bisulfite-PCR pyrosequencing was used to assess the methylation status of LINE-1 and Alu repeats as a proxy of global DNA methylation levels, as described previously. 30, 31 Samples were run on the Pyromark Q24 pyrosequencer (Qiagen) according to manufacturer's instructions. DNA methylation levels for each sample were calculated as the average of the three interrogated CpG sites on each assay. Fully methylated and fully unmethylated control samples were included in all procedures to act as assay controls. Genome-wide DNA methylation array processing 500ng of genomic DNA from each sample was treated with sodium bisulfite in duplicate, using the EZ-96 DNA methylation kit (Zymo Research) following the manufacturer's standard protocol. Duplicates were pooled and the samples (PFC n = 46 and CER n = 46) were assessed using the Illumina Infinium HumanMethylation450 BeadChip (Illumina Inc.) run on the HiScan System (Illumina Inc.). All samples were randomized with respect to gender and disease status to avoid batch effects, and processed on eight BeadChips.
Methylomic data processing and analysis Light gray boxes indicate non-significant results. Dark gray boxes indicate that no comparison was made (X-chromosome-linked genes were compares to females only whereas Y-chromosome-linked genes were compared with males only). annotation data for each probe obtained using the Bioconductor package illuminahumanv4.db.
Signal intensities were extracted using Illumina GenomeStudio software (Illumina Inc.) and imported into R 58 using the methylumi and minfi packages. 59, 60 Multi-dimensional scaling plots of variable probes on the X-and Y-chromosome were used to check concordance between predicted and reported sex for each individual (see the "Results and Discussion" section). The comparison of non-CpG SNP probes on the array confirmed that the PFC and CER were sourced from the same individual where expected. Raw β values of CpG probes within brain regionspecific differentially methylated regions (DMRs) (extracted from ref. 61 ) were used to confirm that the predicted and reported brain region corresponded for each sample. Probes containing a SNP with MAF > 5% within 10 bp of the CG target site based on the Illumina annotation data (n = 35 413) and non-CG probes (n = 65) were removed. Further stringent data quality control and processing steps were conducted using the dasen function in the wateRmelon package as previously described. 62 The pfilter function was used to filter data by beadcount and detection P value to stringently control for poor quality probes (PFC n = 5623 probes and CER n = 10 417 probes removed across all samples). Prior to statistical analyses cross-reactive probes co-hybridizing to the sex-chromosomes, as previously identified, 57 were removed. The pnorm function used to identify differentially methylated CpG sites in the 47,XXY patient and the comb-p package 63 was used to identify 500bp regions of 2 or more adjacent differentially-methylated probes. The identified regions of differential DNA methylation were compared with copy number variation (CNV) data of the 47,XXY patient to screen for overlaps with any large genomic aberrations.
Genome-wide expression array processing An amount of 100 ng RNA from each sample (PFC n = 47 and CER n = 48) was biotinylated and amplified using the Illumina TotalPrep RNA Amplification kit (Life Technologies) to produce cRNA. cRNA was quantitated using a NanoDrop NO-1000 (Thermo Fisher Scientific) and RediPlate 96 RiboGreen RNA Quantitation Kit (Life Technologies). Genome-wide expression was assessed using the Illumina HumanHT-12 v4 Expression BeadChip (Illumina Inc.) according to manufacturer's instruction.
Expression data processing and analysis Signal intensities for each probe were extracted using Illumina GenomeStudio software (Illumina Inc.) and imported into R using the lumi package within Bioconductor. 64 Initial quality control checks using functions within lumi identified clear outlying samples, which were removed from subsequent analyses (PFC n = 5, CER n = 4). The sex of the samples was checked by comparing the sex predicted by the expression levels of the XIST gene with the reported sex for each individual (see the "Results and Discussion" section). Probes targeting transcripts of genes in the vicinity of brain region-specific DMRs 61 were used to confirm that the predicted brain region corresponded with the reported region for each sample. Remaining samples were processed using the lumi 64 and MBCB 65 Bioconductor packages in R. During processing, probes with a detection P value > 0.01 across all samples were considered non-detectable and removed from subsequent analysis. The ComBat function within the sva package in R 66 was used to adjust the data to remove batch effects. The pnorm function was used to identify differentially expressed transcripts in the 47,XXY sample. Genes identified as differentially expressed were compared with the CNV data of the 47,XXY patient to record overlaps with large genomic aberrations.
Genome-wide CNV detection 200ng of genomic DNA from each prefrontal cortex sample were genotyped using the Illumina HumanOmniExpress BeadChip (Illumina Inc.). All samples were randomized with respect to gender and disease status to avoid batch effects. Illumina GenomeStudio was used to call genotypes (using the HumanOmniExpress-12v1_C.egt cluster file) with the default GenCall cut-off of 0.15. To compare the sex predicted by the genetic data with the reported sex for each individual previously published recommendations were followed. 67 PLINK was used to assess the heterozygosity rate of the probes on the X-chromosome 68 (see the "Results and Discussion" section). Autosomal CNVs were called using PennCNV.
69
PCR-based sex-typing assay A PCR-based sex-typing assay was performed as described previously. 70 In brief, the X and Y amelogenin (AMELX ) sequences were amplified, with amplicons distinguished on the basis of size; the X-chromosome produces a 977bp amplicon, whereas the Y-chromosome produces a 788bp amplicon.
X-Chromosome Inactivation assay
The allelic X-Chromosome Inactivation (XCI) ratios of both tissues of the 47,XXY sample were determined by assessing DNA methylation in the proximity of a polymorphic repeat (CAG) n in the human androgen receptor (AR) gene, as described previously. 71, 72 In brief, 50 ng of genomic DNA was incubated with HpaII, MspI or water in triplicate. The digestion product was amplified using fluorescently labeled primers flanking the polymorphic repeat (CAG) n . An ABI3130 (Life Technologies) was used to separate the fluorescently labeled amplification products and quantify the peak heights of each allele. The XCI ratio was then calculated as previously described. 40 
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